Company intelligence / Profile preview

Firebrand River Capital

Carson City, Nevada, United Statessec.gov ↗

Ownership: Private
Development stage: Other

Overview

Firebrand River Capital is a venture capital and private equity investment management company focused on the life sciences sector. It was founded in 2022 by Michael Bigham and is managed by experienced leaders with deep backgrounds in biopharmaceuticals and healthcare investing. The firm's leadership includes individuals with prior executive roles at major biotech companies such as Paratek Pharmaceuticals, Gilead Sciences, Corixa Corp., Coulter Pharmaceuticals, and Abingworth LLP. The fund invests in innovative life science companies but does not itself develop therapeutics or maintain its own clinical pipeline.

Industry: Investors

Beyond the preview

Go deeper on Firebrand River Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Firebrand River Capital.

Explore the full profile